| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | EVP & CMO | Common Stock | 72.5K | $127K | $1.75 | 02 Feb 2023 | Direct |
| ALPINE IMMUNE SCIENCES, INC. | Chief Medical Officer | Stock Option (Right to buy) | 200K | 02 Oct 2023 | Direct | ||
| RIGEL PHARMACEUTICALS INC | EVP & CMO | Employee Stock Option (right to buy) | 100K | 26 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALPN | ALPINE IMMUNE SCIENCES, INC. | 02 Oct 2023 | 1 | $0 | 4 | Chief Medical Officer | 04 Oct 2023, 17:14 |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | 02 Oct 2023 | 0 | $0 | 3 | Chief Medical Officer | 04 Oct 2023, 17:11 |
| RIGL | RIGEL PHARMACEUTICALS INC | 02 Feb 2023 | 1 | -$8.95K | 4 | EVP & CMO | 06 Feb 2023, 16:40 |
| RIGL | RIGEL PHARMACEUTICALS INC | 26 Jan 2023 | 1 | $0 | 4 | EVP & CMO | 30 Jan 2023, 20:45 |
| RIGL | RIGEL PHARMACEUTICALS INC | 28 Dec 2022 | 1 | $0 | 4 | EVP & CMO | 30 Dec 2022, 15:30 |
| RIGL | RIGEL PHARMACEUTICALS INC | 24 Jan 2022 | 2 | $0 | 4 | EVP & CMO | 26 Jan 2022, 19:46 |
| RIGL | RIGEL PHARMACEUTICALS INC | 04 Nov 2021 | 1 | $0 | 4 | EVP & CMO | 05 Nov 2021, 18:59 |